The company
BioCryst Pharmaceuticals, Inc.
BCRX · Nasdaq
BCRX stood above a rising 150-day average in 25 of the last 52 weekly readings, and has been out of that trend for the last 6 weeks. It is 15.0% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 6
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $6.7M
- Officials’ trades on record
- 5
- Institutions holding
- 300 (+14)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 25 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
5 disclosed lines: House 5, Senate 0, executive 0; 2 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31 | bought | $1k–$15k | 10 Jul 2026filed 4 Sep 2026 |
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31 | bought | $1k–$15k | 13 Nov 2025filed 15 Dec 2025 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | boughtjoint | $1k–$15k | 16 Oct 2023filed 11 Nov 2023 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | soldjoint | $1k–$15k | 15 Sep 2023filed 15 Oct 2023 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | boughtjoint | $1k–$15k | 11 Aug 2022filed 16 Sep 2022 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Amy E. McKeeDirector | sold | 11,180at $8.97 | 18 May 2026filed 19 May 2026 |
| Alane P. BarnesChief Legal Officer | sold | 62,500at $9.54 | 13 May 2026filed 15 May 2026 |
| Theresa HeggieDirector | sold | 49,933at $10.11 | 20 Mar 2026filed 24 Mar 2026 |
| Alane P. BarnesChief Legal Officer | sold | 150,000at $9.15 | 16 Mar 2026filed 18 Mar 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 23,893,036$238.9M | +1,242,048+5.5% |
| RA CAPITAL MANAGEMENT, L.P.unchanged · filed 14 Aug 2026 | 15,827,186$158.3M | 00.0% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 15,191,098$151.9M | +2,982,738+24.4% |
| DEERFIELD MANAGEMENT COMPANY, L.P.added · filed 14 Aug 2026 | 15,096,403$151.0M | +58,403+0.4% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 11,364,236$113.6M | +228,474+2.1% |
| VANGUARD PORTFOLIO MANAGEMENT LLCreduced · filed 13 Aug 2026 | 11,139,158$111.4M | -105,467−0.9% |
| TCG Crossover Management, LLCunchanged · filed 14 Aug 2026 | 11,020,968$110.2M | 00.0% |
| PERCEPTIVE ADVISORS LLCadded · filed 14 Aug 2026 | 10,308,888$103.1M | +2,874,855+38.7% |
| Jupiter Topco LLCnew · filed 14 Aug 2026 | 9,540,764$95.3M | +9,540,764 |
| Vestal Point Capital, LPadded · filed 14 Aug 2026 | 8,300,000$83.0M | +1,275,000+18.1% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
From its SEC filings
Analyst forecasts
No analyst forecasts yet.